Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Group of Schizophrenia”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableUnknownNCT03965598
What this trial is testing

Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group

Who this might be right for
Schizophrenia
Second Xiangya Hospital of Central South University 200
Testing effectiveness (Phase 2)Study completedNCT00567710
What this trial is testing

A Six-week, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multi-center, Phase II Study

Who this might be right for
Schizophrenia
BioLineRx, Ltd. 360
Large-scale testing (Phase 3)WithdrawnNCT01234298
What this trial is testing

SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Negative Symptoms of Schizophrenia
Shire
Testing effectiveness (Phase 2)Study completedNCT00722176
What this trial is testing

Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020

Who this might be right for
Schizophrenia
BioLineRx, Ltd. 220
Large-scale testing (Phase 3)Study completedNCT00297947
What this trial is testing

High Dose of Quetiapine in Treating Subjects With Treatment Refractory Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Manhattan Psychiatric Center 60
Large-scale testing (Phase 3)Ended earlyNCT01760889
What this trial is testing

SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of Schizophrenia

Who this might be right for
Schizophrenia
Shire 1
Not applicableUnknownNCT04365621
What this trial is testing

The Clinical and Socio-demographic Characteristics of Young People Aged 12 to 25 Consulting on Ambulatory Structures in the Seine Saint-Denis

Who this might be right for
Psychosis
Januel 900
Not applicableStudy completedNCT01923701
What this trial is testing

Cognitive Behavioral Therapy for the Prevention of Paranoia in Adolescents at High Risk

Who this might be right for
ARMSAPSProdromal Symptoms
Weill Medical College of Cornell University 13
Post-approval studies (Phase 4)Study completedNCT00202306
What this trial is testing

Indicated Prevention of Psychotic Disorders With Low-dose Lithium

Who this might be right for
SchizophreniaBipolar DisorderPsychotic Disorders
Melbourne Health 30
Not applicableStudy completedNCT05042739
What this trial is testing

Early Identification and Predictive Parsing for High Risk Group of Schizophrenia

Who this might be right for
High Risk Group of Schizophrenia
Wuhan Mental Health Centre 189
Not applicableStudy completedNCT05532683
What this trial is testing

Feasibility Trial of a Lifestyle Intervention for CHR-P

Who this might be right for
Prodromal SchizophreniaPsychosisPsychological Disorder+1 more
University of California, Los Angeles 9